DBAY and ERES IV Fund offers to acquire Alliance Pharma for 62.5 pence per share

LONDON: DBAY Affiliates and the ERES IV Fund have agreed to acquire Alliance Pharma for 62.5 pence per share in cash, valuing Alliance at approximately £349.7 million on a fully diluted basis. Shareholders can opt for cash or exchange shares for loan notes, converting to B ordinary shares in Midco. DBAY aims to delist Alliance, citing the…